These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38716318)

  • 1. Multinational experience with next-generation sequencing: opportunity to identify transthyretin cardiac amyloidosis and Fabry disease.
    Silva SME; Chaves AVF; Antunes M; Costabel JP; da Fonseca AA; Furtado A; Gomez-Mesa JE; Gutiérrez FJM; Caspi O; Maksimova I; Maski M; Micheletti C; Pena JLB; Ribeiro MG; Rodríguez-González MJ; Tufekcioglu O; Onay H
    Cardiovasc Diagn Ther; 2024 Apr; 14(2):294-303. PubMed ID: 38716318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology.
    Savostyanov K; Pushkov A; Zhanin I; Mazanova N; Trufanov S; Pakhomov A; Alexeeva A; Sladkov D; Asanov A; Fisenko A
    Orphanet J Rare Dis; 2022 May; 17(1):199. PubMed ID: 35578305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Definition of Sarcomeric and Non-Sarcomeric Gene Mutations in Hypertrophic Cardiomyopathy Patients: A Multicenter Diagnostic Study Across Türkiye.
    Oktay V; Tüfekçioğlu O; Yılmaz DÇ; Onrat E; Karabulut D; Çelik M; Balcıoğlu AS; Sucu MM; Özdemir G; Kaya H; Kış M; Güven B; Bağdatoğlu O; Turhan Çağlar FN; Yüksel UÇ; Düzen İV; Barutçu A; Şimşir ÖS; Başarıcı İ; Parspur A; Dalgıç O; Arıcan Özlük FÖ; Evlice M; Sağ S; Deniz MF; Öcal A; Gazi E; Şen T; Özdabakoğlu O; Bayar Çakıcı N; Bakır EO; Ülgen Kunak A; Çaylı G; Gül Taşdelen A; Akşit E; Uslu Çil Ş; Onay H
    Anatol J Cardiol; 2023 Nov; 27(11):628-638. PubMed ID: 37466024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthyretin amyloidosis: a phenocopy of hypertrophic cardiomyopathy.
    Vermeer AMC; Janssen A; Boorsma PC; Mannens MMAM; Wilde AAM; Christiaans I
    Amyloid; 2017 Jun; 24(2):87-91. PubMed ID: 28475415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.
    Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH
    Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of
    Lopes LR; Futema M; Akhtar MM; Lorenzini M; Pittman A; Syrris P; Elliott PM
    Amyloid; 2019 Dec; 26(4):243-247. PubMed ID: 31554435
    [No Abstract]   [Full Text] [Related]  

  • 7. Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype.
    Cappelli F; Zampieri M; Fumagalli C; Nardi G; Del Monaco G; Matucci Cerinic M; Allinovi M; Taborchi G; Martone R; Gabriele M; Ungar A; Moggi Pignone A; Marchionni N; Di Mario C; Olivotto I; Perfetto F
    J Intern Med; 2021 Jun; 289(6):831-839. PubMed ID: 33615623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awareness of Fabry disease in cardiology: A gap to be filled.
    Brito D; Cardim N; Lopes LR; Belo A; Mimoso J; Gonçalves L; Madeira H;
    Rev Port Cardiol (Engl Ed); 2018 Jun; 37(6):457-466. PubMed ID: 29801713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Screening for Pathogenic Transthyretin Variants Finds Evidence of Underdiagnosed Amyloid Cardiomyopathy From Health Records.
    Carry BJ; Young K; Fielden S; Kelly MA; Sturm AC; Avila JD; Martin CL; Kirchner HL; Fornwalt BK; Haggerty CM;
    JACC CardioOncol; 2021 Oct; 3(4):550-561. PubMed ID: 34746851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy.
    Mademont-Soler I; Mates J; Yotti R; Espinosa MA; Pérez-Serra A; Fernandez-Avila AI; Coll M; Méndez I; Iglesias A; Del Olmo B; Riuró H; Cuenca S; Allegue C; Campuzano O; Picó F; Ferrer-Costa C; Álvarez P; Castillo S; Garcia-Pavia P; Gonzalez-Lopez E; Padron-Barthe L; Díaz de Bustamante A; Darnaude MT; González-Hevia JI; Brugada J; Fernandez-Aviles F; Brugada R
    PLoS One; 2017; 12(8):e0181465. PubMed ID: 28771489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions: Methodological issues and clinical implications.
    Tini G; Sessarego E; Benenati S; Vianello PF; Musumeci B; Autore C; Canepa M
    Eur J Clin Invest; 2021 Dec; 51(12):e13665. PubMed ID: 34390490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic profile of hypertrophic cardiomyopathy in Tunisia: Is it different?
    Jaafar N; Girolami F; Zairi I; Kraiem S; Hammami M; Olivotto I
    Glob Cardiol Sci Pract; 2015; 2015():16. PubMed ID: 26779504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid heart disease mimicking hypertrophic cardiomyopathy.
    Mörner S; Hellman U; Suhr OB; Kazzam E; Waldenström A
    J Intern Med; 2005 Sep; 258(3):225-30. PubMed ID: 16115295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies.
    Vio R; Angelini A; Basso C; Cipriani A; Zorzi A; Melacini P; Thiene G; Rampazzo A; Corrado D; Calore C
    J Clin Med; 2021 May; 10(9):. PubMed ID: 34062949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy.
    Cecconi M; Parodi MI; Formisano F; Spirito P; Autore C; Musumeci MB; Favale S; Forleo C; Rapezzi C; Biagini E; Davì S; Canepa E; Pennese L; Castagnetta M; Degiorgio D; Coviello DA
    Int J Mol Med; 2016 Oct; 38(4):1111-24. PubMed ID: 27600940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy.
    Lee SP; Ashley EA; Homburger J; Caleshu C; Green EM; Jacoby D; Colan SD; Arteaga-Fernández E; Day SM; Girolami F; Olivotto I; Michels M; Ho CY; Perez MV;
    Circ Heart Fail; 2018 Sep; 11(9):e005191. PubMed ID: 30354366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide screening of Fabry disease in patients with hypertrophic cardiomyopathy in Czech Republic.
    Zemánek D; Januška J; Honěk T; Čurila K; Kubánek M; Šindelářová Š; Zahálková L; Klofáč P; Laštůvková E; Lichnerová E; Aiglová R; Lhotský J; Vondrák J; Dostálová G; Táborský M; Kasper D; Linhart A
    ESC Heart Fail; 2022 Dec; 9(6):4160-4166. PubMed ID: 36087038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial Work Appraisal in Transthyretin Cardiac Amyloidosis and Nonobstructive Hypertrophic Cardiomyopathy.
    de Gregorio C; Trimarchi G; Faro DC; De Gaetano F; Campisi M; Losi V; Zito C; Tamburino C; Di Bella G; Monte IP
    Am J Cardiol; 2023 Dec; 208():173-179. PubMed ID: 37852127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Genetic Architecture of Hypertrophic Cardiomyopathy in Hungary: Analysis of 242 Patients with a Panel of 98 Genes.
    Sepp R; Hategan L; Csányi B; Borbás J; Tringer A; Pálinkás ED; Nagy V; Takács H; Latinovics D; Nyolczas N; Pálinkás A; Faludi R; Rábai M; Szabó GT; Czuriga D; Balogh L; Halmosi R; Borbély A; Habon T; Hegedűs Z; Nagy I
    Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626289
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.